Loading...
XSHE000788
Market cap475mUSD
Jan 10, Last price  
5.85CNY
1D
-4.26%
1Q
2.09%
Jan 2017
-58.83%
Name

PKU HealthCare Corp Ltd

Chart & Performance

D1W1MN
XSHE:000788 chart
P/E
78.60
P/S
1.59
EPS
0.07
Div Yield, %
0.11%
Shrs. gr., 5y
1.09%
Rev. gr., 5y
-1.08%
Revenues
2.19b
+5.61%
428,257,365472,032,808500,267,848547,556,809552,520,167879,448,4851,299,099,8731,955,689,2961,947,941,1892,316,469,2692,265,817,5352,010,726,3512,070,262,4562,145,918,0882,315,796,4292,509,080,0511,977,422,1472,236,776,3762,077,355,1842,193,796,737
Net income
44m
-20.23%
12,113,64613,005,91013,272,51614,089,55014,386,31565,334,195270,041,685115,198,06176,172,43578,020,484025,028,59812,559,06734,261,00545,178,54750,188,59639,181,47843,143,83855,605,25044,356,578
CFO
122m
-56.31%
34,721,6521,053,22524,750,11900135,545,890110,610,08579,113,11096,188,34489,074,893165,991,410408,667,74800204,374,3340059,142,996278,896,753121,843,415
Dividend
Jul 16, 20240.026 CNY/sh

Profile

PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, neuropsychiatric, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.
URL
http://www.pku-hc.com/
IPO date
Jun 16, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,193,797
5.61%
2,077,355
-7.13%
Cost of revenue
2,086,853
1,883,199
Unusual Expense (Income)
NOPBT
106,944
194,156
NOPBT Margin
4.87%
9.35%
Operating Taxes
29,937
14,793
Tax Rate
27.99%
7.62%
NOPAT
77,007
179,363
Net income
44,357
-20.23%
55,605
28.88%
Dividends
(3,871)
Dividend yield
0.10%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
35,091
148,739
Long-term debt
47,085
84,945
Deferred revenue
13,137
11,737
Other long-term liabilities
12,090
13,201
Net debt
(392,068)
(399,836)
Cash flow
Cash from operating activities
121,843
278,897
CAPEX
(63,197)
Cash from investing activities
Cash from financing activities
FCF
(5,938)
529,543
Balance
Cash
457,253
633,520
Long term investments
16,990
3
Excess cash
364,554
529,652
Stockholders' equity
1,165,835
1,301,078
Invested Capital
1,140,718
1,050,656
ROIC
7.03%
14.75%
ROCE
7.10%
12.29%
EV
Common stock shares outstanding
596,191
595,987
Price
6.71
-9.81%
7.44
8.61%
Market cap
4,000,439
-9.78%
4,434,146
8.61%
EV
3,607,724
4,034,311
EBITDA
156,986
242,138
EV/EBITDA
22.98
16.66
Interest
7,160
18,478
Interest/NOPBT
6.70%
9.52%